BioCentury
ARTICLE | Clinical News

Mubodina regulatory update

July 21, 2008 7:00 AM UTC

EMEA's Committee for Orphan Medical Products (COMP) issued a positive opinion to grant Orphan Drug designation for Adienne's Mubodina to treat atypical hemolytic uremic syndrome (aHUS). The recombinan...